VR Logo

Dishman Carbogen Amcis Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

43 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 2007

Chairman: Janmejay R Vyas

Managing Director: Arpit J Vyas

Group: Dishman Pharma

Listing: NSE: DCAL, BSE: 540701

Headquarters: Ahmedabad, Gujarat

Website: www.dishmangroup.com

Key Facts

Market cap: R 2,576.73 Cr

Revenue (TTM): R 1,911.77 Cr

Earnings (TTM): R -165.13 Cr

Cash: R 267.59 Cr

Total Debt: R 1,056.16 Cr

Promoters' ownership: 59.32%

Liquidity: High

52 Week range: R 63.60 - 216.80

Face value: R2.00

Shares outstanding: 15,67,83,095

9 Years Aggregate:

  • CFO: 1,383.46 Cr
  • EBITDA: 1,967.38 Cr
  • Net Profit: 691.82 Cr

Stock Performance

Time Period Dishman Carbogen Amcis S&P BSE Healthcare S&P BSE Small Cap
YTD18.3412.4724.14
1 month47.848.139.29
3 months33.1611.9714.50
1 Year117.4161.00112.63
3 Years-22.0022.138.02
5 Years--9.4215.05
10 Years--14.9210.41
As on 12-May-2021
Year Dishman Carbogen Amcis S&P BSE Small Cap S&P BSE Healthcare
202076.7032.1161.45
2019-63.80-6.85-3.55
2018-28.94-23.41-5.89